Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in NERV — Minerva Neurosciences, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$167,992
+$164,698 QoQ
Shares Held
30,269
+1461.9% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 58 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. NERV ranks #262 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in NERV

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $167,992 30,269
2025-03-31 $3,294 1,938
2024-12-31 $4,306 1,938
2024-09-30 $5,174 1,938
2024-06-30 $6,182 1,938
2024-03-31 $7,690 2,981
2023-12-31 $12,176 1,980
2023-09-30 $13,648 1,978
2023-06-30 $18,060 1,976
2023-03-31 $3,159 1,975
2022-12-31 $3,138 1,974
2022-09-30 $18,210 1,973
2022-06-30 $7,178 2,169
2022-03-31 $13,072 15,751
2021-12-31 $600 750
2021-09-30 $1,304 750
2021-06-30 $1,639 707
2021-03-31 $1,837,888 629,414
2020-12-31 $312,852 133,698
2020-09-30 $107,601 33,837
2020-06-30 $125,046 34,639
2020-03-31 $112,971 18,766